Open Orphan Investor Presentation – 2021 a good year, 2022 will be a great year

Open Orphan plc (LON:ORPH) Chief Executive Officer Yamin ‘Mo’ Khan talks through the FY2021 Financial Results and the outlook for 2022.

Mo covers topics:
The Vision,
The Numbers,
Overview,
Key Strategic Value Adding Initiatives,
Summary Financial Highlights,
Attractive Market Dynamics,
Growth of Vaccines & Anti-Virals,
Outlook,
Investment Case

Open Orphan (LON ORPH) is the world leader in testing infectious & respiratory disease products using human challenge studies addressing the growing infectious disease market.

You might also enjoy reading  Open Orphan win £6.2m Influenza human challenge study contract
Find more news, interviews, share price & company profile here for:
Open Orphan plc

Share this presentation

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp

More News